Discover 180 paid clinical trials in Maine. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maine offers nearby opportunities for both healthy volunteers seeking paid studies and individuals with specific health conditions to participate in valuable research. Major research centers in Portland, Bangor, and Augusta are actively recruiting, providing easy access to advanced medical care and new treatment options.
Filter
1
Filter results
Results: 180
Featured
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
for
Breast Cancer
Location: East Patchogue NY, The Bronx NY, New Brunswick NJ,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07100106
Phase1, Phase2, Recruiting
Featured
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
for
Neovascular Age-related Macular Degeneration
Location: Portland ME, Poughkeepsie NY, Bloomfield NJ, Norfolk VA,
Sponsor: Genentech, Inc.
Sex: All
Age: 50+
Code: NCT04853251
Recruiting
Featured
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
for
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer,
Location: Scarborough ME, Boston MA, Providence RI, Jamaica NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06065748
Phase3, Recruiting
Active & Responsive
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Location: Portland ME, Boston MA, Worcester MA, Lebanon NH,
Sponsor: Chris Goss
Sex: All
Age: 6+
Code: NCT05548283
Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention